4.7 Meeting Abstract

Factors critical for the acquisition of antibody after SARS-CoV-2 vaccination in malignant lymphoma patients

Journal

ANNALS OF ONCOLOGY
Volume 33, Issue -, Pages S501-S501

Publisher

ELSEVIER
DOI: 10.1016/j.annonc.2022.05.179

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available